about
Neuroendocrine hormone amylin in diabetesThe therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.Pramlintide and the treatment of diabetes: a review of the data since its introduction.Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primatesIncretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.Diabetes mellitus: new challenges and innovative therapies.GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunitiesAcetaminophen overdose associated with double serum concentration peaks.Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptideCentral and peripheral regulation of food intake and physical activity: pathways and genesSynchronized dual pulse gastric electrical stimulation induces activation of enteric glial cells in rats with diabetic gastroparesis.The alpha-cell as target for type 2 diabetes therapy.The receptive function of hypothalamic and brainstem centres to hormonal and nutrient signals affecting energy balance.Amylin-mediated control of glycemia, energy balance, and cognition.A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.Amylin.Implications of peptide assemblies in amyloid diseases.Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetes.Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications.Normal physical activity obliterates the deleterious effects of a high-caloric intake.A break in the brake mechanism in diabetes: a cause of postprandial hyperglycemia.Acetaminophen overdose with altered acetaminophen pharmacokinetics and hepatotoxicity associated with premature cessation of intravenous N-acetylcysteine therapy.Role of Incretin Axis in Inflammatory Bowel Disease.The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity.KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
P2860
Q26751000-FEE7D712-DF5B-443C-8A50-6A687908F730Q33851630-73611511-281D-4B16-B28F-15DB51C25864Q33896433-7F069961-A9E8-4694-BF1B-434A8C54940DQ34150227-488131E3-FF1D-49C2-8C17-2C64FAF0870AQ35690970-301730CE-79A9-4490-8BBE-982B208BECBBQ36117595-A18040AD-2E3D-457D-AA69-7D01BAB0C8C2Q36153247-60EAC68B-C294-416A-9FEE-FBD3DBBFF2A9Q36367854-34DE82B2-E9E9-4DDB-9143-B7A084B855D8Q36808109-40DDC175-EEEF-41F8-B691-1303BC06F8DBQ36975704-5A364D87-57A3-4A98-9A3B-540FE7EF0EC9Q37204432-FF69400C-3F7A-4CD0-B22E-991B55FED71FQ37730687-E541DEAF-5F99-4C2F-A360-EF945A07A83BQ37977335-647E94A5-8D5B-4FDB-A3B2-3FAF27B1CAC3Q38038929-563600C0-DE19-46A0-BC40-37FA8F7B18E4Q38753342-E42EEB63-C5FA-48B0-B6BB-ADE9E97DDB9EQ39008520-6C9A0394-6C57-4FF7-A396-D4AF44661E49Q39293507-7A909DA6-C1A7-4457-9B23-6CFDEFED4C48Q39431937-E75089C9-A4D3-41ED-BEC4-35776C91DADBQ39538576-AFBB9E14-0E22-4424-91DD-8D37FB69CD38Q41845491-EE074650-EEB3-495F-A580-CC1D6319C3F0Q42241562-2A115B3D-06BD-445E-8850-B359AD596D0BQ43242144-6358BFAE-A78D-469F-9F1B-5C2A53FE15DAQ46482982-40A9900F-2AB7-480C-BCC2-BEB0F432C333Q47103249-883E5FE1-B63A-483C-9343-601D547E100AQ47296897-4B86430E-CE53-4D45-8DF7-366E44726AFAQ47323414-4D63C8C9-D7D1-4FA9-BD11-460C508EC7B1Q58798600-9C4B6CAE-07D1-489D-B484-BBD85ED94302
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition of gastric emptying.
@ast
Inhibition of gastric emptying.
@en
type
label
Inhibition of gastric emptying.
@ast
Inhibition of gastric emptying.
@en
prefLabel
Inhibition of gastric emptying.
@ast
Inhibition of gastric emptying.
@en
P1476
Inhibition of gastric emptying.
@en
P2093
Andrew Young
P304
P356
10.1016/S1054-3589(05)52006-4
P577
2005-01-01T00:00:00Z